| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -2,513 | -212 |
| Depreciation | 0 | 0 |
| Gain on disposal of property and equipment | 81 | 81 |
| Impairment loss on fixed assets | 0 | 0 |
| Impairment loss on rou assets | 0 | 0 |
| Gain on lease termination | 0 | 0 |
| Impairment of prepaid research and development | 0 | 0 |
| Equity-based compensation expense | 87 | 54 |
| Change in fair value of warrant liability | 391 | -1,094 |
| Accretion/amortization of investment securities | 0 | 0 |
| Reduction in carrying amount of operating lease right of use asset | 0 | 0 |
| Prepaid expenses and other current assets | 84 | -537 |
| Prepaid research and development, net of current portion | 0 | 0 |
| Accounts payable and accrued expenses | -1,236 | -1,204 |
| Operating lease liabilities | 0 | 0 |
| Other assets | 0 | 0 |
| Net cash used in operating activities | -3,436 | -2,000 |
| Purchases of marketable securities | 0 | 0 |
| Proceeds from maturity of marketable securities | 0 | 0 |
| Purchases of property and equipment | 0 | 0 |
| Proceeds from the sale of property and equipment | 167 | 167 |
| Net cash provided by investing activities | 167 | 167 |
| Payments on finance lease obligations | 0 | 0 |
| Proceeds from issuance of common stock in connection with at-the-market offering, net of issuance costs-At The Market Offering | 0 | 0 |
| Proceeds from employee stock purchases and exercise of stock options | 0 | 0 |
| Proceeds from exercise of pre-funded warrants-Pre Funded Warrants | 0 | 0 |
| Net cash provided by financing activities | 0 | 0 |
| Net decrease in cash, cash equivalents and restricted cash | -3,269 | -1,833 |
| Cash and cash equivalents at beginning of period | 18,910 | - |
| Cash and cash equivalents at end of period | 15,641 | - |
SYNLOGIC, INC. (SYBX)
SYNLOGIC, INC. (SYBX)